IL13 and Alzheimer disease: To examine alterations in gene expression, RNA sequencing and qPCR analyses of ear tissue were performed and showed that topical RGRN-305-treated mice exhibited significantly reduced AD-related cytokine expression of Il1b, Il4, Il6 and Il13 compared with drug-vehicle-treated mice (Figure 5).